Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001125345-18-000068
Filing Date
2018-05-21
Accepted
2018-05-21 16:52:59
Documents
1
Period of Report
2018-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152693596609406.html 4  
1 FORM 4 wf-form4_152693596609406.xml 4 3874
  Complete submission text file 0001125345-18-000068.txt   5232
Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Issuer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Fust Matthew K (Reporting) CIK: 0001397266 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36112 | Film No.: 18850256